Bioscience Animal Health Public Company Limited

THAMSE:BIS-F Stock Report

Market Cap: ฿1.1b

Bioscience Animal Health Past Earnings Performance

Past criteria checks 5/6

Bioscience Animal Health has been growing earnings at an average annual rate of 0.8%, while the Healthcare industry saw earnings growing at 11.8% annually. Revenues have been growing at an average rate of 7.3% per year. Bioscience Animal Health's return on equity is 8.8%, and it has net margins of 2.6%.

Key information

0.8%

Earnings growth rate

-14.2%

EPS growth rate

Healthcare Industry Growth23.6%
Revenue growth rate7.3%
Return on equity8.8%
Net Margin2.6%
Last Earnings Update30 Sep 2024

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How Bioscience Animal Health makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

THAMSE:BIS-F Revenue, expenses and earnings (THB Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 242,393632850
30 Jun 242,487622820
31 Mar 242,464582840
31 Dec 232,426512790
30 Sep 232,346482640
30 Jun 232,287452650
31 Mar 232,215452620
31 Dec 222,213562600
30 Sep 222,181602750
30 Jun 222,095662710
31 Mar 222,091772680
31 Dec 211,986722620
30 Sep 211,911752500
31 Dec 201,782622620
31 Dec 191,881302450

Quality Earnings: BIS-F has high quality earnings.

Growing Profit Margin: BIS-F's current net profit margins (2.6%) are higher than last year (2%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: BIS-F's earnings have grown by 0.8% per year over the past 5 years.

Accelerating Growth: BIS-F's earnings growth over the past year (31.6%) exceeds its 5-year average (0.8% per year).

Earnings vs Industry: BIS-F earnings growth over the past year (31.6%) exceeded the Healthcare industry 11.1%.


Return on Equity

High ROE: BIS-F's Return on Equity (8.8%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies